Jim Simons
RXST icon

Jim Simons’s RxSight RXST Stock Holding History

Jim Simons’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Buy
140,693
+80,293
+133% +$485K ﹤0.01% 2487
2026
Q1 		$372K Buy
+60,400
New +$502K ﹤0.01% 2726
2025
Q4 		– Sell
-138,700
Closed -$1.25M – 3684
2025
Q3 		$1.25M Sell
138,700
-287,700
-67% -$2.53M ﹤0.01% 2374
2025
Q2 		$5.54M Sell
426,400
-25,200
-6% -$379K 0.01% 1461
2025
Q1 		$11.4M Buy
451,600
+90,100
+25% +$2.68M 0.02% 943
2024
Q4 		$12.4M Buy
361,500
+183,300
+103% +$8.27M 0.02% 886
2024
Q3 		$8.81M Sell
178,200
-51,900
-23% -$2.66M 0.01% 1106
2024
Q2 		$13.8M Buy
230,100
+73,100
+47% +$4.18M 0.02% 760
2024
Q1 		$8.1M Buy
+157,000
New +$7.71M 0.01% 1111
2023
Q3 		– Sell
-38,900
Closed -$1.12M – 4042
2023
Q2 		$1.12M Buy
38,900
+24,600
+172% +$547K ﹤0.01% 2402
2023
Q1 		$239K Buy
+14,300
New +$202K ﹤0.01% 3206

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
No Street GP LP
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jim Simons's RXST Position: Q2 2026 in Review

Jim Simons increased its RxSight (RXST) stake by 133% in Q2 2026, buying an estimated $485K and bringing the position to 140,693 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #2487.

Jim Simons first reported a position in RXST in Q1 2023 and has held it in 11 quarters since. The position peaked at $13.8M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Jim Simons held 140,693 shares of RxSight worth $678K as of Q2 2026.
  • Jim Simons bought 80,293 RxSight shares in Q2 2026, an estimated $485K.
  • RxSight made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2487 holding.
  • Jim Simons first reported a position in RxSight in Q1 2023 and has held it in 11 quarters since.
  • Jim Simons's RxSight position peaked at $13.8M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.